Victoria Aramă *, Alina Adriana Iancu **, Sanda Corneliu ***, Ingrid Linzmeier ****, Violeta Molagic *****
* Victoria Aramă, medic primar, șef de lucrări, Institutul de Boli lnfecțioase “Prof Dr. Matei Balș”, UMF “Carol Davila” București
** Alina Adriana Iancu – absolvent al Facultății de Medicină Generală, UMF “Carol Davila” București, 2001
*** Sanda Corneliu – absolvent al Facultății de Medicină Generală, UMF “Carol Davila” București, 2001
**** Ingrid Linzmeier, rezident Boli lnfecțioase, anul II, Institutul de Boli lnfecțioase “Prof Dr. Matei Balș”, București
***** Violeta Molagic – rezident Boli lnfecțioase, anul V, Institutul de Boli lnfecțioase “Prof Dr. Matei Balș”, București
Abstract
In the last decades there have been changes in the epidemiology of VZV (Varicella – Zoster virus) infections. The morbidity peak of Varicella has moved from the small children to the adolescent and adult, with higher risk of severe and complicated clinical forms. The incidence of Herpes-Zoster and PHN has grown due to the ageing of the population and the increased number of supressed patients.These epidemiologic changes led to a different management of the Varicella and Herpes-Zoster patient, that is promoting a larger acceptance of the antiviral therapy and anti-VZV vaccination.